Abstracts of the 12th International Leprosy Congress, New Delhi, India. Session II, No. 54.
Sansarricq, H. 1981. Leprosy in the world today. Lepr. Rev. 52(suppl. 1):15–31.
Sansarricq, H. 1982. The Kellersberger Memorial Lecture, 1981: the general situation of leprosy in the world. Ethiop. Med. J. 20:89–106.
Shepard, C.C. 1983. Animal vaccine studies with Mycobacterium leprae. Int. J. Leprosy 51:519–523.
Shepard, C.C., and D.H.McRae. 1965. Mycobacterium leprae in mice: Minimal infectious dose, relationship between staining quality and infectivity and effect of cortisone. J. Bacteriol. 89:365–372.
Shepard, C.C., L.I.Walker, and R.Van Landingham. 1978. Heat stability of Mycobacterium leprae immunogenicity. Infect. Immun. 22:87–93.
SPRTTD (Special Programme for Research and Training in Tropical Diseases). 1983. Primary resistance to dapsone among untreated patients in Bamako and Chingleput. Report of the Subcommittee on Clinical Trials, Scientific Working Group on the Chemotherapy of Leprosy (THELEP). Leprosy Rev. 54:177–183.
SPRTTD (Special Programme for Research and Training in Tropical Diseases). 1985. Leprosy. Pp. 8/1–8/19 in Tropical Disease Research. Seventh Programme Report, 1 January 1983–31 December 1984. Geneva: World Health Organization.
Talwar, G.P., and A.Fotedar. 1983. Two candidate antileprosy vaccines—current status of their development. Int. J. Lepr. 51:550–552.
Wolf, R.H., B.J.Gormus, L.N.Martin, G.B.Baskin, G.P.Walsh, W.M. Meyers, and C.H.Binford. 1985. Experimental leprosy in three species of monkeys. Science 227:529–531.
Young, R.A., V.Mehra, D.Sweetser, T.Buchanan, J.Clark-Curtis, R.W.Davis, and B.R.Bloom. 1985. Genes for the major antigens of the parasite causing leprosy. Nature 316:450–452.